Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea flag South Korea · Delayed Price · Currency is KRW
30,300
-150 (-0.49%)
At close: Aug 14, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Liquid Products
156.49B
Log In
Log In
Log In
Log In
Upgrade
Liquid Products Growth
3.49%
Log In
Log In
Log In
Log In
Upgrade
Ampoule and Vial
45.80B
Log In
Log In
Log In
Log In
Upgrade
Ampoule and Vial Growth
9.46%
Log In
Log In
Log In
Log In
Upgrade
Testing and Inspection
806.00M
Log In
Log In
Log In
Log In
Upgrade
Testing and Inspection Growth
1.90%
Log In
Log In
Log In
Log In
Upgrade
Other
1.10B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
2.51%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
South Korea
204.19B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
4.23%
Log In
Log In
Log In
Log In
Upgrade